CSBR

Over the past six months, Champions Oncology, Inc.'s stock price has decreased by 10.14%. On April 9, 2026, Champions Oncology announced plans to present new data at AACR 2026. On March 30, 2026, Brian Alexander was appointed to the Board. On March 12, 2026, the company reported its financial results for the third quarter of fiscal year 2026, with total revenue of $16.6 million and a GAAP loss from operations of approximately $275,000. On December 15, 2025, Champions Oncology reported record quarterly service revenue of $14.9 million.